Novel bispecific aptamer targeting PD-1 and nucleolin for cancer immunotherapy
Abstract Background Immune checkpoint blockade (ICB) is a promising strategy for cancer treatment and has achieved remarkable clinical results. Further improvement of ICB efficacy may advance cancer immunotherapy and has evident medical importance. Here in this study, a PD-1 aptamer was functionaliz...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2023-03-01
|
| Series: | Cancer Nanotechnology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12645-023-00177-8 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|